The economic burden of spinal muscular atrophy

Journal of Medical Economics

Volumn 19, Issue 8, 2016, Pages 822-826

  Armstrong, Edward P ^a,b   Malone, Daniel C ^a,b   Yeh, Wei Shi ^c   Dahl, Georg J ^d   Lee, Rees L ^e   Sicignano, Nicholas ^f  

^a Strategic Therapeutics   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c BIOGEN   (United States)

^d NAVAL MEDICAL CENTER PORTSMOUTH   (United States)

^e Environmental Health Effects Laboratory   (United States)

^f Health ResearchTx   (United States)

Author keywords

Muscle disease; Neuromuscular disease; Spinal muscular atrophy

Indexed keywords

ADULT; AGE; ARTICLE; ARTIFICIAL VENTILATION; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; COST BENEFIT ANALYSIS; EARLY DIAGNOSIS; ECONOMIC EVALUATION; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; OUTPATIENT; PRESCHOOL CHILD; PRESCRIPTION; SCHOOL CHILD; SEX DIFFERENCE; SPINAL MUSCULAR ATROPHY; ADOLESCENT; ECONOMICS; HEALTH SERVICE; INFANT; INSURANCE; NEWBORN; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; UNITED STATES; UTILIZATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HEALTH EXPENDITURES; HEALTH SERVICES; HUMANS; INFANT; INFANT, NEWBORN; INSURANCE CLAIM REVIEW; MALE; MUSCULAR ATROPHY, SPINAL; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84974718000     PISSN: 13696998     EISSN: 1941837X     Source Type: Journal    
DOI: 10.1080/13696998.2016.1198355     Document Type: Article

References (14)

1. S.Ogino, D.G.Leonard, H.Rennert,. Genetic risk assessment in carrier testing for spinal muscular atrophy. Am J Med Genet 2002;110:301–7
2. A.D’Amico, E.Mercuri, F.D.Tiziano,. Spinal muscular atrophy. Orphanet J Rare Dis 2011;6:71
3. A.Mesfin, P.D.Sponseller, A.I.Leet Spinal muscular atrophy: manifestations and management. J Am Acad Orthopaed Surg 2012;20:393–401
4. Anon. Learn about SMA: Cure SMA. IL, USA: Cure SMA; 2016. http://www.curesma.org. [Last accessed on March 25]
5. E.A.Sugarman, N.Nagan, H.Zhu,. Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72,400 specimens. Eur J Hum Genet EJHG 2012;20:27–32
6. M.R.Lunn, C.H.Wang Spinal muscular atrophy. Lancet 2008;371:2120–33
7. C.H.Wang, R.S.Finkel, E.S.Bertini,. Consensus statement for standard of care in spinal muscular atrophy. J Child Neurol 2007;22:1027–49
8. N.Kayadjanian, A.Burghes, R.S.Finkel,. SMA-EUROPE workshop report: Opportunities and challenges in developing clinical trials for spinal muscular atrophy in Europe. Orphanet J Rare Dis 2013;8:44
9. J.Larkindale, W.Yang, P.F.Hogan,. Cost of illness for neuromuscular diseases in the United States. Muscle & Nerve 2014;49:431–8
10. C.L.Bladen, R.Thompson, J.M.Jackson,. Mapping the differences in care for 5000 spinal muscular atrophy patients, a survey of 24 national registries in North America, Australasia and Europe. J Neurol 2014;261:152–63
11. J.Montes, A.M.Gordon, S.Pandya,. Clinical outcome measures in spinal muscular atrophy. J Child Neurol 2009;24:968–78.
12. C.Gregoretti, G.Ottonello, M.B.Chiarini Testa,. Survival of patients with spinal muscular atrophy type 1. Pediatrics 2013;131:e1509–14
13. T.J.Lemoine, K.J.Swoboda, S.L.Bratton,. Spinal muscular atrophy type 1: are proactive respiratory interventions associated with longer survival? Pediat Crit Care Med Pediatr Crit Care Med. 2012;13:e161–5. doi: 10.1097/PCC.0b013e3182388ad1
14. Y.Qian, S.McGraw, J.Henne,. Understanding the experiences and needs of individuals with spinal muscular atrophy and their parents: a qualitative study. BMC Neurol 2015;15:217